Accuracy of Fecal Occult Blood Screening for Colorectal Neoplasia: A Prospective Study Using Hemoccult and HemoQuant Tests

JAMA: The Journal of the American Medical Association

Volumn 269, Issue 10, 1993, Pages 1262-1267

  Ahlquist, David A ^a   Wieand, Harry S ^a   Moertel, Charles G ^a   McGill, Douglas B ^a   Loprinzi, Charles L ^a   O’connell, Michael J ^a   Mailliard, James A ^b   Gerstner, James B ^b   Pandya, Kishan ^c   Ellefson, Ralph D ^a  

^a MAYO CLINIC   (United States)

^b North Central Cancer Treatment Group Rochester   (United States)

^c AMC Cancer Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; COLON POLYP; COLORECTAL TUMOR; DIAGNOSTIC ACCURACY; HUMAN; MAJOR CLINICAL STUDY; OCCULT BLOOD; OCCULT BLOOD TEST; PRIORITY JOURNAL; RECTUM POLYP;

ADULT; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; HUMAN; MASS SCREENING; MIDDLE AGE; OCCULT BLOOD; PROSPECTIVE STUDIES; REAGENT KITS, DIAGNOSTIC; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027403221     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1993.03500100060028     Document Type: Article

References (50)

1. 1989 Survey of physicians’ attitudes and practices in early cancer detection. CA Cancer J Clin. 1989;40:77-101.
2. US Preventive Services Task Force. Recommendations for fecal occult blood screening. JAMA. 1989;261:586.
3. Simon JB. Occult blood screening for colorectal carcinoma: a critical review. Gastroenterology. 1985; 88:820-837.
4. Frank JW. Occult blood screening for colorectal carcinoma: the yield and the costs. Am J Prev Med. 1985;1:18-24.
5. Knight KK, Fielding JE, Battisita RN. Occult blood screening for colorectal cancer. JAMA. 1989; 261:587-593.
6. Agrez M, Evans D, Duggan J. Faecal occult blood testing for colorectal cancer: luxury or necessity? Aust N Z J Surg. 1990;60:451-454.
7. Chamberlain J. Is screening for colorectal cancer worthwhile? Br J Cancer. 1990;62:1-3.
8. Ransohoff DF, Lang CA. Screening for colorectal cancer. N Engl J Med. 1991;325:37-41.
9. Ahlquist DA. Occult blood screening: obstacles to effectiveness. Cancer. 1992;70:1259-1265.
10. Ahlquist DA. Approach to the patient with occult gastrointestinal bleeding. In: Yamada T, ed. Textbook of Gastroenterology. Philadelphia, Pa: JB Lippincott Co; 1991:616-633.
11. Gnauck R. Dickdarmkarzinom-screening mit Haemoccult. Leber Magen Darm. 1977;7:32-35.
12. Mandel JS, Bond JH, Bradley M, et al. Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers. Gastroenterology. 1989;97:597-600.
13. Kronborg O, Fenger C, Olsen J, Beck K, Sondergaard O. Repeated screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol. 1989;24:599-606.
14. Hardcastle JD, Chamberlain J, Sheffield J, et al. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Lancet. 1989;1:1160-1164.
15. Kewenter J, Bjork S, Haglind E, et al. Screening and rescreening for colorectal cancer: a controlled trial of fecal occult blood testing in 27 700 subjects. Cancer. 1988;62:645-651.
16. Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Ann Intern Med. 1990;112:328-333.
17. Morris JB, Stellato TA, Guy BB, et al. A critical analysis of the largest reported mass fecal occult blood screening program in the United States. Am J Surg. 1991;161:101-106.
18. Crowley ML, Freeman LD, Mottet MD, et al. Sensitivity of guaiac-impregnated cards for the detection of colorectal neoplasia. J Clin Gastroenterol. 1983;5:127-130.
19. Songster CL, Barrows GH, Jarrett DO. Immunochemical detection of fecal occult blood—the fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer. Cancer. 1980; 45(suppl 5):1099-1102.
20. Dybdahl JH, Daae LNW, Larsen S, et al. Occult fecal blood loss determined by a 51Cr method and chemical tests in patients referred for colonoscopy. Scan J Gastroenterol. 1984;19:245-254.
21. Ahlquist DA, McGill DB, Schwartz S, et al. Fecal blood levels in health and disease: a study using HemoQuant. N Engl J Med. 1985;312:1422-1428.
22. Tate JJT, Northway J, Royle GT, Tayler I. Faecal occult blood testing in symptomatic patients: comparison of three tests. Br J Surg. 1990;77:523-526.
23. Macrae FA, St John DJB. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology. 1982;82:891-898.
24. Pye G, Jackson J, Thomas WM, Hardcastle JD. Comparison of Coloscreen self-test and Haemoccult faecal occult blood tests in the detection of colorectal cancer in symptomatic patients. Br J Surg. 1990;77:630-631.
25. St John DJB, Young GP, McHutchinson JG, et al. Comparison of specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia. Ann Intern Med. 1992;117:376-382.
26. Eddy DM. Screening for colorectal cancer. Ann Intern Med. 1990;113:373-384.
27. Eddy DM. Comparing benefits and harms: the balance sheet. JAMA. 1990;263:2493-2505.
28. Eddy DM, Nugent TW, Eddy JF, et al. Screening for colorectal cancer in a high-risk population: results of a mathematical model. Gastroenterology. 1987;92:682-692.
29. Illingworth DG. Influence of diet on occult blood tests. Gut. 1965;6:595-599.
30. Macrae FA, St John DJB, Caligiore P, et al. Optimal dietary conditions for Hemoccult testing. Gastroenterology. 1982;82:899-905.
31. Schentag JJ. False positive ‘Hemoccult’ reaction with cimetidine. N Engl J Med. 1980;303:110.
32. Jaffe RM, Kasten B, Young DS, et al. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med. 1975;83:824-826.
33. Stroehlein JR, Fairbanks VG, Go VL, et al. Hemoccult stool tests: false-negative results due to storage of specimens. Mayo Clin Proc. 1976;51: 548-552.
34. Ostrow JD, Mulvaney CA, Hansell JR, et al. Sensitivity and reproducibility of chemical tests for fecal occult blood with an emphasis on false-positive reactions. Am J Dig Dis. 1973;18:930-940.
35. Ahlquist DA, Schwartz S, Isaccson J, et al. A stool collection device: the first step in occult blood testing. Ann Intern Med. 1988;108:609-616.
36. Goldschmiedt M, Ahlquist DA, Wieand HS, et al. Measurement of degraded fecal hemoglobin-heme to estimate gastrointestinal site of occult bleeding: appraisal of its clinical utility. Dig Dis Sci. 1988; 33:605-608.
37. Schwartz S, Dahl J, Ellefson M, Ahlquist DA. The HemoQuant test: a specific and quantitative assay of heme (hemoglobin) in feces and other materials. Clin Chem. 1983;29:2061-2067.
38. Ahlquist DA, McGill DB, Schwartz S, et al. HemoQuant, a new quantitative assay for fecal hemoglobin: comparison with Hemoccult. Ann Intern Med. 1984;101:297-302.
39. Ahlquist DA, McGill DB, Fleming JL, et al. Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer. 1989;63:1826-1830.
40. Ellefson RD, Larson MS, Schwartz S, Ellefson ME. The HemoQuant test remodeled for the busy clinical laboratory. Clin Chem. 1986;32:1142-1143.
41. Beam CA, Wieand HS. A statistical method for the comparison of a discrete diagnostic test with several continuous diagnostic tests. Biometrics. 1991;47:907-919.
42. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics. 1955;11:375-386.
43. Jahn H, Joergensen OK, Kronborg O, Fenger C. Can Hemoccult II replace colonoscopy after radical surgery for colorectal cancer or after polypectomy? Dis Colon Rectum. 1992;35:253-256.
44. Iwase T. Evaluation of an immunochemical fecal occult blood test by reversal passive hemagglutination compared with Hemoccult II screening for colorectal cancer. In: Young GP, Saito H, eds. Fecal Occult Blood Tests: Current Issues and New Tests. San Jose, Calif: Smith Kline Diagnostics Inc; 1992:90-95.
45. Bang KM, Tillett S, Hoar SK, Blair A, McDougall V. Sensitivity of fecal Hemoccult testing and flexible sigmoidoscopy for colorectal cancer screening. J Occup Med. 1986;28:709-713.
46. Frommer DJ. Hemoccult test and colorectal cancer. Gastroenterology. 1990;99:607-608.
47. Ransohoff DF, Lang CA. Small adenomas detected during fecal occult blood test screening for colorectal cancer: the impact of serendipity. JAMA. 1990;263:76-78.
48. McGill DB, Ahlquist DA. Demystification of the occult with HemoQuant. Gastroenterol Clin Biol. 1987;11:191-193.
49. Selby JV, Friedman GD, Quesenberry CP, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-657.
50. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572-1575.